Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US$200 million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
Bayer Announces US$2.2 Billion Investment in New Ohio Pharmaceutical Manufacturing Site
Bayer is investing US$22 billion to establish a new pharmaceutical manufacturing facility in New Albany, Ohio, as part of its strategy to strengthen production capacity and support future medicine demand in the United States The development follows more than US$7 billion invested
Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia
Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa, Slovakia The development is part of an approximately US$94 million investment EUR 80 million
Onyx Scientific to Invest Over US$2 Million (£1.5 Million) in Sunderland GMP Facility Expansion
Onyx Scientific is investing more than US$2 Million 15 Million to expand its Good Manufacturing Practice GMP facilities at its Sunderland, UK site The investment will increase capacity for commercial
Evonik to Invest Over US$109 million in Vancouver GMP Manufacturing Facility
Evonik is investing more than US$109 million approximately EUR 93 million in a new GMP drug product manufacturing facility for lipidbased drug delivery in Vancouver, Canada The project will expand Evoniks
Genentech to Invest US$750 Million in Oregon Device Fill-Finish Facility
Genentech, a member of the Roche Group, plans to invest approximately US$750 million in a new device fillfinish manufacturing facility at its 75acre campus in Hillsboro, Oregon The project will add endtoend manufacturing
Bristol Myers Squibb Announces US$2.3Billion Houston Manufacturing Campus
Bristol Myers Squibb BMS has selected Houston, Texas, for a new US$23 billion multimodal manufacturing campus at Generation Park The approximately 600,000squarefoot facility will expand BMS domestic
Resilience and Lilly Expand Ohio Manufacturing Facility with US$750 Million Investment
Resilience, a technologydriven contract development and manufacturing organisation CDMO, has expanded its strategic partnership with Eli Lilly and Company to increase domestic production
Evonik Announces US$100 Million Modernization of U.S. Drug Substance CDMO Facility
Evonik has announced a US$100 million investment to modernize its Tippecanoe Labs manufacturing site in Lafayette, Indiana, over the next five years The investment is aimed at strengthening the companys US drug substance
Johnson & Johnson Invests $1B to Expand U.S. Vision Manufacturing & Distribution
Johnson Johnson has announced an investment of more than $1 billion to expand its Vision manufacturing operations in Jacksonville, Florida The project is designed to increase domestic manufacturing, packaging and distribution capacity for the company
